AN ITALIAN RETROSPECTIVE-PROSPECTIVE OBSERVATIONAL STUDY ON THE USE OF ZANUBRUTINIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (AZALEA)

20/02/2025
16/10/2025
EU PAS number:
EUPAS1000000437
Study
Ongoing
Documents
Study protocol
Study results
Study report
Other information